| Nano Codelivery of Oxaliplatin and Folinic Acid Achieves Synergistic Chemo-Immunotherapy with 5-Fluorouracil for Colorectal Cancer and Liver Metastasis J Guo, Z Yu, M Das, L Huang ACS Nano, 2020 | 152 | 2020 |
| Targeted drug delivery to melanoma Q Liu, M Das, Y Liu, L Huang Advanced Drug Delivery Reviews 127, 208-221, 2018 | 127 | 2018 |
| Transient and local expression of chemokine and immune checkpoint traps to treat pancreatic cancer L Miao, J Li, Q Liu, R Feng, M Das, CM Lin, TJ Goodwin, O Dorosheva, ... ACS nano 11 (9), 8690-8706, 2017 | 124 | 2017 |
| Local blockade of interleukin 10 and CXC motif chemokine ligand 12 with nano-delivery promotes antitumor response in murine cancers L Shen, J Li, Q Liu, W Song, X Zhang, K Tiruthani, H Hu, M Das, ... ACS nano 12 (10), 9830-9841, 2018 | 110 | 2018 |
| Nanoparticle delivery of RIG-I agonist enables effective and safe adjuvant therapy in pancreatic cancer M Das, L Shen, Q Liu, TJ Goodwin, L Huang Molecular Therapy 27 (3), 507-517, 2019 | 75 | 2019 |
| Leveraging Biomaterials for Cancer Immunotherapy: Targeting Pattern Recognition Receptors W Song, M Das, Y Xu, X Si, Y Zhang, Z Tang, X Chen Materials Today Nano, 2019 | 43 | 2019 |
| RNA Interference-Based Cancer Drugs: The Roadblocks, and the “Delivery” of the Promise M Das, S Musetti, L Huang Nucleic Acid Therapeutics, 2018 | 38 | 2018 |
| Nanotherapeutics for immuno-oncology: a crossroad for new paradigms W Song, M Das, X Chen Trends in cancer 6 (4), 288-298, 2020 | 30 | 2020 |
| High performance immunochromatographic assay combined with surface enhanced Raman spectroscopy IH Cho, M Das, P Bhandari, J Irudayaraj Sensors and Actuators B: Chemical 213, 209-214, 2015 | 25 | 2015 |
| Chitosan derivatives cross-linked with iodinated 2, 5-dimethoxy-2, 5-dihydrofuran for non-invasive imaging P Ghosh, M Das, AP Rameshbabu, D Das, S Datta, S Pal, AB Panda, ... ACS Applied Materials & Interfaces 6 (20), 17926-17936, 2014 | 24 | 2014 |
| Liposomal nanostructures for drug delivery in gastrointestinal cancers M Das, L Huang Journal of Pharmacology and Experimental Therapeutics, 2018 | 20 | 2018 |
| Tumor neoantigen heterogeneity impacts bystander immune inhibition of pancreatic cancer growth M Das, X Zhou, Y Liu, A Das, B Vincent, J Li, R Liu, L Huang Translational Oncology 13 (12), 2020 | 12 | 2020 |
| Nano-trapping CXCL13 reduces regulatory B cells in tumor microenvironment and inhibits tumor growth L Shen, J Li, Q Liu, M Das, W Song, X Zhang, K Tiruthani, O Dorosheva, ... Journal of Controlled Release 343, 303-313, 2022 | 11 | 2022 |
| π-Stacking assisted redox active peptide–gallol conjugate: Synthesis of a new generation of low-toxicity antimicrobial silver nanoparticles M Das, K Senapati, SS Panda, P Bhattacharya, S Jana, SM Mandal, ... RSC advances 6 (88), 85254-85260, 2016 | 9 | 2016 |
| Nano-delivery of Gemcitabine Derivative as a Therapeutic Strategy in a Desmoplastic KRAS Mutant Pancreatic Cancer M Das, J Li, M Bao, L Huang The AAPS Journal 22, 1-10, 2020 | 8 | 2020 |
| Inhaled treprostinil in patients with pulmonary hypertension associated with interstitial lung disease with less severe haemodynamics: a post hoc analysis of the INCREASE study J Weatherald, SD Nathan, K El-Kersh, RG Argula, HM DuBrock, ... BMJ Open Respiratory Research 11 (1), e002116, 2024 | | 2024 |
| Promoting inclusive language in biomedical publishing: Original Abstracts from the 18th Annual Meeting of ISMPP C Farnsworth, M Das Current Medical Research and Opinion, 2022 | | 2022 |
| Drug Delivery Strategies to Treat Desmoplastic and Immunosuppressive Pancreatic Cancer M Das University of North Carolina at Chapel Hill, 2020 | | 2020 |
Leaf HuangProfessor Emeritus, University of North Carolina at Chapel HillVerified email at email.unc.edu
